Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Clinical trial NCT00139776 · COMPLETED

Trial details

NCT number: NCT00139776
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis, Hip

Start date: 2005-07-01
Primary completion: 2008-02-01
Enrollment: 875

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.